We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TKNO market cap is 344.13M. The company's latest EPS is USD -0.5005 and P/E is -12.97.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.87M | 9.29M | 9.61M | 9.58M | 9.27M |
| Operating Income | -13.05M | -7.99M | -5.1M | -7.43M | -5.63M |
| Net Income | -10.66M | -8.1M | -5.36M | -7.57M | -5.72M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31.3M | 36.89M | 41.42M | 36.68M | 37.75M |
| Operating Income | 4.66M | -12.01M | -49.66M | -35.56M | -26.15M |
| Net Income | 3.57M | -9.8M | -47.47M | -36.78M | -26.75M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 128.59M | 120.82M | 115.35M | 124.1M | 118.77M |
| Total Liabilities | 38.55M | 37.44M | 36.43M | 36.83M | 36.38M |
| Total Equity | 90.04M | 83.38M | 78.93M | 87.27M | 82.39M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.91M | 166.51M | 152.26M | 128.59M | 118.77M |
| Total Liabilities | 10.51M | 23.31M | 52.38M | 38.55M | 36.38M |
| Total Equity | 52.41M | 143.2M | 99.89M | 90.04M | 82.39M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.81M | -6.56M | -9.4M | -11.46M | -12.39M |
| Investing | -7.74M | 13k | -102k | -25.86M | -27.28M |
| Financing | 12.8M | -343k | -390k | 14.98M | 14.89M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.51M | -9.07M | -27.4M | -18.81M | -12.39M |
| Investing | -1.74M | -17.52M | -28.15M | -7.74M | -27.28M |
| Financing | -1.6M | 110.79M | 10.27M | 12.8M | 14.89M |
| Market Cap | 344.13M |
| Price to Earnings Ratio | -12.97 |
| Price to Sales Ratio | 9.19 |
| Price to Cash Ratio | 93.52 |
| Price to Book Ratio | 4.21 |
| Dividend Yield | - |
| Shares Outstanding | 53.44M |
| Average Volume (1 week) | 336.57k |
| Average Volume (1 Month) | 517.88k |
| 52 Week Change | 278.82% |
| 52 Week High | 10.37 |
| 52 Week Low | 1.155 |
| Spread (Intraday) | 0.05 (0.77%) |
| Company Name | Alpha Teknova Inc |
| Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
| Website | https://www.teknova.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
